Research of ribomomal protein L23 in tumor progression / 国际肿瘤学杂志
Journal of International Oncology
; (12): 835-837, 2016.
Article
en Zh
| WPRIM
| ID: wpr-501903
Biblioteca responsable:
WPRO
ABSTRACT
Ribosomal protein L23 is a new target for gene therapy of cancer.It participates in tumor progression by activating p53,inactivating murine double minute 2,regulating the carcinogenic activity of c-Myc,inducing the multi-drug resistance,and affecting the biologic behaviour of tumors.Generally,it′s con-sidered to be a potential prognostic factor in human cancers.
Texto completo:
1
Índice:
WPRIM
Tipo de estudio:
Prognostic_studies
Idioma:
Zh
Revista:
Journal of International Oncology
Año:
2016
Tipo del documento:
Article